• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病性胱氨酸病的不对称眼部表现;一例报告

Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report.

作者信息

Helmi Hala A, El Mansoury Jeylan, Al Hazzaa Selwa, Al Zoba Abdulaziz, Dirar Qais S

机构信息

College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Department of Ophthalmology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

出版信息

Am J Case Rep. 2019 Sep 4;20:1308-1313. doi: 10.12659/AJCR.916737.

DOI:10.12659/AJCR.916737
PMID:31481649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6741281/
Abstract

BACKGROUND Infantile nephropathic cystinosis is the most common and severe variant of cystinosis, which is a rare autosomal recessive condition related to a defect in the transportation of the protein cystine resulting in its deposition in various organs. Due to the rarity of this condition, only 1 case with extensive ocular involvement has been found in the English-language literature. Here, we report a second such case to highlight the significance of early diagnosis in avoiding devastating but preventable vision loss. CASE REPORT We describe the extensive asymmetrical ocular involvement in a 22-year-old woman who had nephropathic cystinosis since childhood. Despite frequent follow up and systemic and topical cysteamine therapy, she developed ocular complications, including increased intraocular pressure, uveitis, and retinal changes with complete loss of vision in her left eye. In addition, her general condition requires a renal transplant in the near future. CONCLUSIONS Ophthalmologists should be aware of cystinosis and the sequalae of ocular involvement in this disease, despite its rarity. Identification of the earliest corneal deposits should not be overlooked, especially in the context of other systemic manifestations that are indicative of the nephropathic variant of cystinosis.

摘要

背景

婴儿型肾病性胱氨酸病是胱氨酸病最常见且最严重的类型,胱氨酸病是一种罕见的常染色体隐性疾病,与蛋白质胱氨酸转运缺陷有关,导致其在各个器官中沉积。由于这种疾病罕见,英文文献中仅发现1例有广泛眼部受累的病例。在此,我们报告第二例此类病例,以强调早期诊断对于避免严重但可预防的视力丧失的重要性。病例报告:我们描述了一名自童年起就患有肾病性胱氨酸病的22岁女性广泛不对称的眼部受累情况。尽管进行了频繁随访以及全身和局部半胱胺治疗,但她仍出现了眼部并发症,包括眼压升高、葡萄膜炎和视网膜病变,左眼完全失明。此外,她的总体状况需要在近期进行肾移植。结论:眼科医生应了解胱氨酸病以及该疾病眼部受累的后遗症,尽管其罕见。不应忽视最早角膜沉积物的识别,尤其是在存在其他提示肾病性胱氨酸病变体的全身表现的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/52ae637c238e/amjcaserep-20-1308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/a1f0aafdd4c6/amjcaserep-20-1308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/e670ab3121ed/amjcaserep-20-1308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/96055346fa36/amjcaserep-20-1308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/52ae637c238e/amjcaserep-20-1308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/a1f0aafdd4c6/amjcaserep-20-1308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/e670ab3121ed/amjcaserep-20-1308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/96055346fa36/amjcaserep-20-1308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/6741281/52ae637c238e/amjcaserep-20-1308-g004.jpg

相似文献

1
Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report.肾病性胱氨酸病的不对称眼部表现;一例报告
Am J Case Rep. 2019 Sep 4;20:1308-1313. doi: 10.12659/AJCR.916737.
2
Ocular changes in nephropathic cystinosis: The course of the gold-dust.肾病型胱氨酸病的眼部变化:金粉尘的病程。
Int Ophthalmol. 2019 Jun;39(6):1413-1418. doi: 10.1007/s10792-018-0954-7. Epub 2018 Jun 18.
3
Nephropathic cystinosis presenting with uveitis: Report of a "Can't See, Can't Pee" situation.以葡萄膜炎为表现的肾病性胱氨酸病:“看不见,尿不出”情况的报告。
Indian J Pathol Microbiol. 2019 Jul-Sep;62(3):457-460. doi: 10.4103/IJPM.IJPM_623_18.
4
Ophthalmic Evaluation of Diagnosed Cases of Eye Cystinosis: A Tertiary Care Center's Experience.眼胱氨酸病确诊病例的眼科评估:一家三级医疗中心的经验
Diagnostics (Basel). 2020 Nov 7;10(11):911. doi: 10.3390/diagnostics10110911.
5
Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine.肾病性胱氨酸病眼部表现的演变:一项使用半胱胺治疗的人群的长期研究
J Pediatr Ophthalmol Strabismus. 2003 May-Jun;40(3):142-6. doi: 10.3928/0191-3913-20030501-07.
6
Follow-up and treatment of renal transplantation with nephropathic cystinosis in central Taiwan.台湾中部肾移植合并肾性胱氨酸病的随访与治疗
Transplant Proc. 2012 Jan;44(1):80-2. doi: 10.1016/j.transproceed.2011.12.071.
7
Multinucleated podocytes as a clue to diagnosis of juvenile nephropathic cystinosis.多核足细胞可作为幼年型肾性胱氨酸病诊断的线索。
Pediatr Nephrol. 2024 Feb;39(2):609-612. doi: 10.1007/s00467-023-06103-9. Epub 2023 Aug 12.
8
Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.肾性胱氨酸病:眼部后段表现及半胱胺治疗的效果
Ophthalmology. 2006 Jun;113(6):1002-9. doi: 10.1016/j.ophtha.2005.12.026. Epub 2006 Apr 17.
9
Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.婴儿型肾病性胱氨酸病的眼部表现及组织病理学:一例报告并文献复习
Surv Ophthalmol. 2007 Jan-Feb;52(1):97-105. doi: 10.1016/j.survophthal.2006.10.006.
10
Follow-up and treatment of adults with cystinosis in the Netherlands.荷兰成年胱氨酸病患者的随访与治疗
Nephrol Dial Transplant. 2002 Oct;17(10):1766-70. doi: 10.1093/ndt/17.10.1766.

引用本文的文献

1
Ocular Involvement in Patients with Infantile Nephropathic Cystinosis.胱氨酸贮积症患儿的眼部受累。
Turk J Ophthalmol. 2024 Aug 28;54(4):235-239. doi: 10.4274/tjo.galenos.2024.89957.
2
The Clinical Manifestations and Disease Burden of Cystinosis in Saudi Arabia: A Single-Tertiary Center Experience.沙特阿拉伯胱氨酸病的临床表现与疾病负担:单三级中心经验
Cureus. 2024 Jan 21;16(1):e52662. doi: 10.7759/cureus.52662. eCollection 2024 Jan.
3
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations.

本文引用的文献

1
Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.用于治疗胱氨酸病患者角膜胱氨酸晶体沉积的盐酸半胱胺滴眼液:一项循证综述
Clin Ophthalmol. 2018 Jan 24;12:227-236. doi: 10.2147/OPTH.S133516. eCollection 2018.
2
A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.一种用于治疗眼型胱氨酸病的新型粘性半胱胺滴眼液:一项开放标签随机对照III期关键研究。
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2275-2283. doi: 10.1167/iovs.16-21080.
3
Cystinosis: a review.
半胱胺滴眼液复方制剂稳定性的局限性与挑战
Pharmaceuticals (Basel). 2021 Dec 21;15(1):2. doi: 10.3390/ph15010002.
胱氨酸病:综述
Orphanet J Rare Dis. 2016 Apr 22;11:47. doi: 10.1186/s13023-016-0426-y.
4
Treatment of corneal cystine crystal accumulation in patients with cystinosis.胱氨酸病患者角膜胱氨酸晶体积聚的治疗
Clin Ophthalmol. 2014 Oct 10;8:2077-84. doi: 10.2147/OPTH.S36626. eCollection 2014.
5
Nephropathic cystinosis: an international consensus document.肾性胱氨酸病:一份国际共识文件。
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4(Suppl 4):iv87-94. doi: 10.1093/ndt/gfu090.
6
A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.一种用于治疗胱氨酸病中角膜胱氨酸结晶的新型局部用半胱胺凝胶制剂:Cystadrops OCT-1研究。
Mol Genet Metab. 2014 Mar;111(3):314-320. doi: 10.1016/j.ymgme.2013.12.298. Epub 2014 Jan 9.
7
Clinical utility gene card for: cystinosis.胱氨酸病的临床实用基因卡片
Eur J Hum Genet. 2014 May;22(5). doi: 10.1038/ejhg.2013.204. Epub 2013 Sep 18.
8
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.半胱氨酸治疗可延缓晚期青少年和成年患者的囊纤维化肾病进展。
Kidney Int. 2012 Jan;81(2):179-89. doi: 10.1038/ki.2011.277. Epub 2011 Sep 7.
9
Craniofacial and dental findings in cystinosis.胱氨酸病的颅面和牙齿表现。
Oral Dis. 2010 Jul;16(5):488-95. doi: 10.1111/j.1601-0825.2010.01662.x. Epub 2010 Mar 9.
10
In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis.肾病性胱氨酸病患者角膜的体内共聚焦显微镜检查和眼前节光学相干断层扫描分析
Ophthalmology. 2009 May;116(5):870-6. doi: 10.1016/j.ophtha.2008.11.021.